• Designed to be a preferred provider of high quality and cost effective pre-clinical contract research
• The CNS CRO service offering utilizes unique proprietary models of neurological diseases
– Parkinson's disease, Alzheimer's disease, ALS, Stroke, Epilepsy, and Schizophrenia
• Functions as an independent state-of-the-art extension of a clients' own discovery process, allowing the client to evaluate candidate neuroprotectants in a timely cost effective manner
• Specializes in a wide range of behavioral testing
– detailed evaluation of various aspects of memory, learning and cognitive decline
• The CNS CRO offers a new standard in pre-clinical neurological disease testing
– Slowly progressive models
– Close parallels to human disease progression
– Sophisticated behavioral testing